Skip to main content

MindImmune Therapeutics

Providence, United States

MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.

$5.0M raised
Mar 2026
Grant

Top Investors

Slater Technology FundPfizer Venture InvestmentsGates Frontier FundAlzheimer's Drug Discovery FoundationDolby Family Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MindImmune Therapeutics

How much funding has MindImmune Therapeutics raised?
MindImmune Therapeutics has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Who are MindImmune Therapeutics's investors?
MindImmune Therapeutics's investors include Slater Technology Fund, Pfizer Venture Investments, Gates Frontier Fund, Alzheimer's Drug Discovery Foundation, Dolby Family Ventures.
Where is MindImmune Therapeutics headquartered?
MindImmune Therapeutics is headquartered in Providence, United States.
What does MindImmune Therapeutics do?
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
What stage is MindImmune Therapeutics at?
MindImmune Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"MindImmune Therapeutics — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/mindimmune-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2026). MindImmune Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/mindimmune-therapeutics
Wikipedia (cite web)
{{cite web |title=MindImmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mindimmune-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .